London, United Kingdom

Kantaraja Chindera

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Tecrea Limited, The Royal Veterinary College. Active years: 2019-2024.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kantaraja Chindera: Innovator in Cell Entry Methods

Introduction

Kantaraja Chindera is a notable inventor based in London, GB. He has made significant contributions to the field of cellular biology through his innovative methods for promoting the entry of agents into cells. With a total of 2 patents, his work is paving the way for advancements in drug delivery systems.

Latest Patents

Chindera's latest patents focus on methods for enhancing the entry of introduced agents into cells. These methods involve complexing the introduced agent with an entry-promoting agent, which includes various forms of polymonoguanide and polybiguanide. The innovative approach also facilitates the formation of nanoparticles, which can improve the efficacy of drug delivery.

Career Highlights

Throughout his career, Kantaraja Chindera has worked with esteemed organizations such as the Royal Veterinary College and Tecrea Limited. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Chindera has collaborated with professionals like Liam Good and Valentina Gburcik, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Kantaraja Chindera's work exemplifies the spirit of innovation in the field of cellular biology. His patents and collaborations highlight his commitment to advancing scientific knowledge and improving drug delivery methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…